Clinical Trial Update: A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton. [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of andecaliximab in people with spinal cord injury at risk for heterotopic ossification (bone growth outs…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heterotopic Ossification

Drugs mentioned

• Andecaliximab

Snippet

Sponsor: Ashibio Inc | Conditions: Heterotopic Ossification (HO) | Phase 1, Phase 2 | Status: RECRUITING